No Detail Found!

Postprandial Anti-diabetic Effects of Various Fractions of Fagonia indica Burm. F. by in Vitro and in Vivo Studies.

Author(s)
Abida Latif University College of Pharmacy, University of the Punjab, Lahore, Pakistan
Rukhsana Anwar University College of Pharmacy, University of the Punjab, Lahore, Pakistan
Nasir Abbas University College of Pharmacy, University of the Punjab, Lahore, Pakistan
Sajid Nawaz Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan
Hamid Turab Mirza Department of Computer Science, COMSATS Institute of Information Technology, LahorE, Pakistan
Atiq-ur-Rehman University College of Pharmacy, University of the Punjab, Lahore, Pakistan; Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan
Abstract
The plant Fagonia indica is used in treating various diseases in folkloric/traditional medicinal system. It is used as a folklore medicine to treat diabetes. No study has been conducted so for to determine a-amylase inhibition for the evaluation of hypoglycemic potential of the plant. So, the aim of this study was for the investigation of in vitro, in vivo anti-diabetic potential and mode of action of various fractions of methanolic extract of the aerial parts of this plant. Various fractions (n-hexane, chloroform, ethyl acetate and n-butanol) from the most active methanolic extract were prepared. Hypoglycemic potential was investigated by a-amylase inhibitory assay. Different concentrations of fractions (20-100 µg/ml) were subjected to in vitro a-amylase inhibitory assay. Assessment of anti-hyperglycemic potential of the most active chloroform fraction exhibiting in vitro a-amylase inhibition was carried out in Wistar albino rat models. Changes in postprandial levels of blood glucose in rat models (normal and diabetic) were examined after starch load with or without chloroform fraction. Chloroform fractions (250 mg/kg and 500 mg/kg b.w.) dose levels were administered to the rats and the samples of blood were taken at 0 h, 0.5 h, 1 h, 2 h and 3 h intervals. In vitro results showed that chloroform fraction at concentration of 100 µg/ml showed maximum a-amylase inhibition (53.11 ± 0.97% with IC50 value of 93.61 ± 4.44 µg/ml) followed by ethyl acetate, n-hexane and n-butanol fractions. The reference standard acarbose (100 µg/ml) showed a-amylase inhibition (68.91 ± 3.09% with IC50 value of 52.99 ± 4.88 µg/ml). In in vivo study, chloroform fractions decreased lesser postprandial blood glucose levels than the standard acarbose at half an hour after meal intake. Chloroform fraction may inhibit hydrolyzing of starch via pancreatic a-amylase. It is concluded that chloroform fraction may have therapeutic potential to prevent prophylactically diabetes type 2.
Publication Details
Page(s) 330-340
Published Journal: Pakistan Journal of Zoology, Volume: 51, Issue: 1, Year: 2019

Request the full text from PASTIC

References
Ahmed , N., 2004.Advanced glycation endproductsrole in pathology of diabetic complications,Diabetes Res. Clin. Pract 09 3 -21
AmericanDiabetes Association, 2012.Diagnosis and classification of diabetes mellitus,Diabetes Care 35 S64 -S71
Apostolidis , E.,Li , L.,Kang , B.H.,Lee , C.M.,Seeram , N.P., 2012.Seasonal influence on phenolic-mediated antihyperglycemic properties of Canadian sugar and red maple leaves using in vitro assay models,Fd. Sci. Biotechnol 21 753 -760
Bailey , C.J., 2003.New approaches to the pharmacotherapy of diabetes,Blackwell Science Ltd., UK 73 21 -73
Biradar , S.M.,Rangani , A.T.,Kulkarni , V.H.,Hanumanthachar , J.,Habbu , P.V.,Smita , D.M., 2010.Prevention of onset of hyperglycemia by extracts of Argyriea cuneata on alloxan-induced diabetic rats,J. Pharm. Res. 3 2186 -2187
Ceriello , A., 2005.Postprandial hyperglycemia and diabetes complications: is it time to treat?,54.1.1 54 1 -7
Eman , A.A., 2011.Morphological, phytochemical and biological screening on three Egyptian species of Fagonia,Acad. Arena 3 18 -27
Fujisawa , T.,Ikegami , H.,Inoue , K.,Kawabata , Y.,Ogihara , T., 2004.Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms,Metabolism 10 387 -390
Ghamarian , A.,Abdollahi , M.,Su , X.,Amiri , A.,Ahadi , A.,Nowrouzi , A., 2012.Effect of chicory seed extract on glucose tolerance test (GTT) and metabolic profile in early and late stage diabetic rats,DARU J. Pharm. Sci. 20 56 -
Gillespie , K.M., 2006.Type 1 diabetes: Pathogenesis and prevention,Canadian med 175 165 -170
Hameed , M.,Ashraf , M.,Al-Quriany , F.,Nawaz , T.,Ahmad , M.S.A.,Younis , A.,Naz , N., 2011.Medicinal flora of the Cholistan desert: A review,Pak. J. Bot. 43 39 -50
Hanhineva , K.,Törrönen , R.,Bondia-Pons , I.,Pekkinen , J.,Kolehmainen , M.,Mykkänen , H.,Poutanen , K., 2010.Impact of dietary polyphenols on carbohydrate metabolism,Int. J. mol. Sci 11 1365 -1402
Hussain , S.N.,Chaudhry , B.A.,Uzair , M.,Qaisar , M.N., 2015.Studies on the analgesic and antiinflammatory effects of Cassia sophera roots,Asian-Pac. J. Trop Dis 15 60820 -9
Jeon , W.J.,Oh , J.S.,Park , M.S.,Ji , G.E., 2013.Antihyperglycemic effect of fermented ginseng in type 2 diabetes mellitus mouse model,Phytother. Res. 27 166 -172
Jo , S.H.,Ka , E.H.,Lee , H.S.,Apostolidis , E.,Jang , H.D.,Kwon , Y.I., 2009.Comparison of antioxidant potential and rat intestinal α-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin,Int. J. appl. Res. Nat. Prod 2 52 -60
Kamtekar , S.,Keer , V.,Patil , V., 2014.Estimation of phenolic content, flavonoid content, antioxidant and alpha amylase inhibitory activity of marketed polyherbal formulation,J. appl. Pharm. Sci. 4 61 -65
Kanauchi , M.,Nakajima , M.,Saito , Y.,Kanauchi , K., 2003.Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus,Metabolism 52 476 -481
Kim , H.H.,Kang , Y.R.,Lee , J.Y.,Chang , H.B.,Lee , K.W.,Apostolidis , E.,Kwon , Y.I., 2018.The postprandial anti-hyperglycemic effect of pyridoxine and its derivatives using in vitro and in vivo animal models,Nutrients 10 285 -
Kwon , Y.I.,Vattem , D.A.,Shetty , K., 2006.Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension,AsianPac. J. clin. Nutr 15 107 -118
Lebovitz , H.E., 1997.Alpha-glucosidase inhibitors,Endocrin. Metab. Clin. N. Am. 8529 70266 -8
Lenzen , S., 2008.The mechanisms of alloxan and streptozotocin-induced diabetes,Diabetologia 51 216 -226
Mahdy , A.,Shehab , N.G., 2015.Hypoglycemic activity of Fagonia indica and Aloe vera in alloxaninduced hypergly-cemia in mice,EC Pharmaceut. Sci. 2 239 -244
Mohan , Y.,Jesuthankaraj , G.N.,RamasamyThangavelu, 2013.Antidiabetic and antioxidant properties of Triticum aestivum in streptozotocin-induced diabetic rats,2013: Article ID 716073 -
OECD, 2008.OECD guidelines for the testing of chemicals, Test 425, -
Patel , D.K.,Kumar , R.,Laloo , D.,Hemalatha , S., 2012.Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity,Asian-Pac. J. Trop. Biomed. 1691 60067 -7
Salehi , P.,Asghari , B.,Esmaeili , M.A.,Dehghan , H.,Ghazi , I., 2013.Glucosidase and-amylase inhibitory effect and antioxidant activity of ten plant extracts traditionally used in Iran for diabetes,J. med. Pl. Res. 7 257 -266
Sharma , S.B.,Nasir , A.,Prabhu , K.M.,Murthy , P.S., 2005.Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus,J. Ethnopharmacol. 10 367 -373
Shi , Z.L.,Liu , Y.D.,Yuan , Y.Y.,Song , D.,Qi , M.F.,Yang , X.J.,Yang , Z.X., 2017.In vitro and in vivo effects of Norathyriol and Mangiferin on α-glucosidase,Biochem. Res. Int. 1206015 -
Singh , S.K.,Rai , P.K.,Jaiswal , D.,Watal , G., 2008.Evidence-based critical evaluation of glycemic potential of Cynodon dactylon,Evid. Based Complem. Alternat. Med 5 415 -420
Singh , S.K., 2012.Post-prandial hyperglycemia,Indian J. Endocrinol. Metab. 16 S245 -247
Subramanian , R.,Asmawi , M.Z.,Sadikun , A., 2008.In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata extract and andrographolide,Acta Biochim. Pol. 55 391 -398
Tucci , S.A.,Boyland , E.J.,Halford , J.C., 2010.The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: A review of current and emerging therapeutic agents,Diabetes Metab. Syndr. Obes. 3 125 -143
Tzeng , T.F.,Liou , S.S.,Chang , C.J.,I.M., 2014.The ethanol extract of Lonicera japonica (Japanese honeysuckle) attenuates diabetic nephropathy by inhibiting p-38 MAPK activity in streptozotocininduced diabetic rats,Planta Med 80 121 -129
Virk , P., 2018.Antidiabetic activity of green gold-silver nanocomposite with Trigonella foenum graecum L. seeds extract on streptozotocin-induced diabetic rats,Pakistan. J. Zool. 50 711 -718
Wild , S.,Roglic , G.,Green , A.,Sicree , R.,King , H., 2004.Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030,Diabetes Care 27 1047 -1053
Yaseen , G.,Ahmad , M.,Zafar , M.,Sultana , S.,Kayani , S.,Cetto , A.A.,Shaheen , S., 2015.Traditional management of diabetes in Pakistan: Ethnobotanical investigation from traditional health practitioners,J. Ethnopharmacol. 07 91 -117
Zafar , M.,Khan , M.A.,Ahmad , M.,Sultana , S.,Qureshi , R.,Tareen, 2010.Authentication of misidentified crude herbal drugs marketed in Pakistan,J. med. Pl. Res. 4 1584 -1593
0

Citations

0

Downloads

191

Views